Boehringer Ingelheim in Oncology
Cancer takes away loved ones, time and untapped potential. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.
We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients.
Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthroughs, first-in-class treatments that can help win the fight against cancer.
Our commitment to innovation has resulted in pioneering treatments for lung cancer and we are advancing a unique pipeline of cancer cell directed agents, immune oncology therapies and intelligent combinations approaches to help combat many cancers.
To find out more about our ongoing collaborations, approved and investigational compounds, oncology meetings and congresses, symposia and other activities sponsored by Boehringer Ingelheim, please follow the link to www.inoncology.com.